UK Edition

Thursday, 30 July 2026

Markets Brief

News, business, world affairs and market coverage

Business

Chlorovinyl Manufacturing Expansion Asserts Westlake Corp (WLK) as a Top Mid-Cap Stock to Own for Decades, According to Hedge Funds

Chlorovinyl Manufacturing Expansion Asserts Westlake Corp (WLK) as a Top Mid-Cap Stock to Own for Decades, According to Hedge Funds

Westlake Corp (NYSE: WLK) has been one of the top mid-cap stocks to own for decades, according to hedge funds. On June 15, Westlake Corp (NYSE:WLK) strengthened its Performance & Essential Materials business by completing the acquisition of a polyvinyl chloride and vinyl chloride monomer production site located in Wilhelmshaven, Germany.

The company completed the acquisition through its German subsidiary Westlake Vinnolit GmbH & Co. KG. The acquired polyvinyl chloride and vinyl chloride monomer production site has the potential to produce 380,000 metric tons of PVC per year, thereby expanding Westlake's global chlorovinyl manufacturing footprint.

The acquired production site's competitive edge stems from its advantageous logistical infrastructure, which includes a deep-water dock that enables efficient raw material supply. Consequently, it is expected to strengthen the company's chlorovinyl production facilities in Europe and North America.

Meanwhile, on July 1, Mizuho reiterated a Neutral rating on the stock but lowered its price target to $88 from $110. The price target cut comes on the research firm lowering price targets for most of its basic chemical targets as focus shifts to technology material stocks.

Westlake Corp (NYSE:WLK) is a global industrial company that manufactures basic petrochemicals, polymers, and building products. They produce the raw chemical building blocks used in everyday items, such as food packaging, medical devices (like IV bags), clean-water piping, and automotive components.

While we acknowledge the potential of WLK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Billionaire Cliff Asness' Top 10 Healthcare Stock Picks and 10 Best Stocks to Buy Now for Good Returns.

Disclosure: None. Follow Insider Monkey on Google News.